Karuna Therapeutics to Present Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2023 Neuroscience Education Institute Congress

Analyses of pooled efficacy data from the EMERGENT program demonstrate significant improvements in schizophrenia symptoms


Analyses extend prior findings that KarXT is generally well tolerated with...

Related Keywords

Stephen Brannan ,Peter Weiden ,Judy Kando ,Renaissance School Of Medicine ,Neuroscience Education Institute ,Karuna Therapeutics Inc ,Exchange Commission ,Stony Brook University ,Nasdaq ,Securities Exchange ,Program Of Kar ,Karuna Therapeutics ,Colorado Springs ,Pooled Results From ,Executive Director ,Field Medical Lead ,Medical Affairs ,Pooled Analysis ,Like Symptoms ,Renaissance School ,New Path ,Targeting Muscarinic Receptor Circuits ,Securities Act ,Securities Exchange Act ,Annual Report ,Markets ,